Argent Trust Co’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Argent Trust Co's NVO Position: Q3 2026 in Review
Argent Trust Co reduced its Novo Nordisk (NVO) stake by 1.9% in Q3 2026, selling an estimated $17.5K and leaving 19,557 shares worth $741K. The position accounts for 0.02% of the portfolio, ranked #406.
Argent Trust Co first reported a position in NVO in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.28M in Q2 2024. 948 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Argent Trust Co held 19,557 shares of Novo Nordisk worth $741K as of Q3 2026.
- Argent Trust Co sold 380 Novo Nordisk shares in Q3 2026, an estimated $17.5K.
- Novo Nordisk made up 0.02% of Argent Trust Co's portfolio in Q3 2026, its #406 holding.
- Argent Trust Co first reported a position in Novo Nordisk in Q4 2020 and has held it in 24 quarters since.
- Argent Trust Co's Novo Nordisk position peaked at $1.28M in Q2 2024.
- 948 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Argent Trust Co's 13F filing for Q3 2026, filed 9 Nov 2026.